83 FR 44640 - National Institute on Aging; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 170 (August 31, 2018)

Page Range		44640-44640
FR Document		2018-18902

Federal Register, Volume 83 Issue 170 (Friday, August 31, 2018)

[Federal Register Volume 83, Number 170 (Friday, August 31, 2018)]
[Notices]
[Page 44640]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-18902]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel; ``Drug Repositioning and Combination Therapy for AD''.
    Date: September 27, 2018.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute on Aging, Gateway Building, Suite 
2C212, 7201 Wisconsin Ave., Bethesda, MD 20892 (Telephone Conference 
Call).
    Contact Person: Alexander Parsadanian, Ph.D., Scientific Review 
Officer, National Institute on Aging, Gateway Building 2C/212, 7201 
Wisconsin Avenue, Bethesda, MD 20892, 301-496-9666, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)

    Dated: August 27, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-18902 Filed 8-30-18; 8:45 am]
BILLING CODE 4140-01-P

44640 Federal Register / Vol. 83, No. 170 / Friday, August 31, 2018 / Notices

confidential trade secrets or commercial Community Influences on Health Behavior provisions set forth in sections
property such as patentable material, Study Section. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
and personal information concerning Date: September 27–28, 2018. as amended. The grant applications and
Time: 8:00 a.m. to 6:00 p.m.
individuals associated with the grant Agenda: To review and evaluate grant
the discussions could disclose
applications, the disclosure of which applications. confidential trade secrets or commercial
would constitute a clearly unwarranted Place: Melrose Hotel, 2430 Pennsylvania property such as patentable material,
invasion of personal privacy. Ave. NW, Washington, DC 20037. and personal information concerning
Name of Committee: National Institute of Contact Person: Ping Wu, Ph.D., Scientific individuals associated with the grant
General Medical Sciences Special Emphasis Review Officer, Center for Scientific Review, applications, the disclosure of which
Panel; MIDAS U24 Coordination Center National Institutes of Health, 6701 Rockledge would constitute a clearly unwarranted
Drive, Room 3166, Bethesda, MD 20892, 301– invasion of personal privacy.
Review.
451–8428, wup4@csr.nih.gov.
Date: October 19, 2018.
Name of Committee: Molecular, Cellular Name of Committee: National Institute on
Time: 2:00 p.m. to 3:30 p.m.
and Developmental Neuroscience Integrated Aging Special Emphasis Panel; ‘‘Drug
Agenda: To review and evaluate grant
Review Group; Neurotransporters, Receptors, Repositioning and Combination Therapy for
applications.
and Calcium Signaling Study Section. AD’’.
Place: National Institutes of Health,
Date: September 27, 2018. Date: September 27, 2018.
Natcher Building, Suite 3AN18, 45 Center
Time: 8:00 a.m. to 6:00 p.m. Time: 12:00 p.m. to 3:00 p.m.
Drive, Bethesda, MD 20892 (Virtual Meeting).
Agenda: To review and evaluate grant Agenda: To review and evaluate grant
Contact Person: Brian R. Pike, Ph.D.,
applications. applications.
Scientific Review Officer, Office of Scientific
Place: The St. Regis Washington DC, 923 Place: National Institute on Aging,
Review, National Institute of General Medical
16th Street NW, Washington, DC 20006. Gateway Building, Suite 2C212, 7201
Sciences, National Institutes of Health, 45
Contact Person: Peter B. Guthrie, Ph.D., Wisconsin Ave., Bethesda, MD 20892
Center Drive, Room 3AN18, Bethesda, MD
Scientific Review Officer, Center for (Telephone Conference Call).
20892, 301–594–3907, pikebr@mail.nih.gov.
Scientific Review, National Institutes of Contact Person: Alexander Parsadanian,
(Catalogue of Federal Domestic Assistance Health, 6701 Rockledge Drive, Room 4182, Ph.D., Scientific Review Officer, National
Program Nos. 93.375, Minority Biomedical MSC 7850, Bethesda, MD 20892, (301) 435– Institute on Aging, Gateway Building 2C/212,
Research Support; 93.821, Cell Biology and 1239, guthriep@csr.nih.gov. 7201 Wisconsin Avenue, Bethesda, MD
Biophysics Research; 93.859, Pharmacology, 20892, 301–496–9666, PARSADANIANA@
Physiology, and Biological Chemistry Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM– NIA.NIH.GOV.
Research; 93.862, Genetics and
18–011: Cutting Edge Informatics Tools for (Catalogue of Federal Domestic Assistance
Developmental Biology Research; 93.88,
Illuminating the Druggable Genome (U01). Program Nos. 93.866, Aging Research,
Minority Access to Research Careers; 93.96,
Date: September 27, 2018. National Institutes of Health, HHS)
Special Minority Initiatives; 93.859,
Time: 12:00 p.m. to 4:00 p.m. Dated: August 27, 2018.
Biomedical Research and Research Training,
Agenda: To review and evaluate grant
National Institutes of Health, HHS) David D. Clary,
applications.
Dated: August 27, 2018. Place: National Institutes of Health, 6701 Program Analyst, Office of Federal Advisory
David D. Clary, Rockledge Drive, Bethesda, MD 20817 Committee Policy.
Program Analyst, Office of Federal Advisory (Virtual Meeting). [FR Doc. 2018–18902 Filed 8–30–18; 8:45 am]
Contact Person: Craig Giroux, Ph.D.,
Committee Policy. BILLING CODE 4140–01–P
Scientific Review Officer, BST IRG, Center
[FR Doc. 2018–18906 Filed 8–30–18; 8:45 am] for Scientific Review, National Institutes of
BILLING CODE 4140–01–P Health, 6701 Rockledge Drive, Room 5150,
Bethesda, MD 20892, 301–435–2204,
DEPARTMENT OF HEALTH AND
girouxcn@csr.nih.gov. HUMAN SERVICES
DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance National Institutes of Health
HUMAN SERVICES Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
Center for Scientific Review; Notice of
National Institutes of Health 93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National Closed Meetings
Center for Scientific Review; Notice of Institutes of Health, HHS)
Pursuant to section 10(d) of the
Closed Meetings Dated: August 27, 2018. Federal Advisory Committee Act, as
David D. Clary, amended, notice is hereby given of the
Pursuant to section 10(d) of the
Program Analyst, Office of Federal Advisory following meetings.
Federal Advisory Committee Act, as Committee Policy.
amended, notice is hereby given of the The meetings will be closed to the
following meetings. [FR Doc. 2018–18899 Filed 8–30–18; 8:45 am] public in accordance with the
BILLING CODE 4140–01–P provisions set forth in sections
The meetings will be closed to the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
public in accordance with the as amended. The grant applications and
provisions set forth in sections DEPARTMENT OF HEALTH AND the discussions could disclose
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., HUMAN SERVICES confidential trade secrets or commercial
as amended. The grant applications and property such as patentable material,
the discussions could disclose National Institutes of Health and personal information concerning
confidential trade secrets or commercial individuals associated with the grant
property such as patentable material, National Institute on Aging; Notice of
applications, the disclosure of which
daltland on DSKBBV9HB2PROD with NOTICES

and personal information concerning Closed Meeting
would constitute a clearly unwarranted
individuals associated with the grant Pursuant to section 10(d) of the invasion of personal privacy.
applications, the disclosure of which Federal Advisory Committee Act, as
would constitute a clearly unwarranted Name of Committee: Genes, Genomes, and
amended, notice is hereby given of the Genetics Integrated Review Group; Molecular
invasion of personal privacy. following meeting. Genetics A Study Section.
Name of Committee: Healthcare Delivery The meeting will be closed to the Date: September 24–25, 2018.
and Methodologies Integrated Review Group; public in accordance with the Time: 8:30 a.m. to 6:00 p.m.

VerDate Sep<11>2014 18:42 Aug 30, 2018 Jkt 244001 PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 E:\FR\FM\31AUN1.SGM 31AUN1

Document Created: 2018-08-31 00:52:53
Document Modified: 2018-08-31 00:52:53

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 27, 2018.
FR Citation		83 FR 44640

83 FR 44640 - National Institute on Aging; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 170 (August 31, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health